login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
AQUESTIVE THERAPEUTICS INC (AQST) Stock News
NASDAQ:AQST - Nasdaq -
US03843E1047
-
Common Stock
- Currency: USD
4.185
-0.02 (-0.36%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AQST Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer
3 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer
10 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
10 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
3 months ago - By: Benzinga
Uncovering Potential: Aquestive Therapeutics's Earnings Preview
18 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
18 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
23 days ago - By: Yahoo Finance
- Mentions:
APLS
H.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA Approval
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
2 months ago - By: Yahoo Finance
- Mentions:
BNTX
AES
TSLA
MRNA
...
BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion
2 months ago - By: Yahoo Finance
- Mentions:
ATYR
ATAI
IBRX
aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential
2 months ago - By: Yahoo Finance
- Mentions:
LXRX
PAHC
MMSI
ITGR
...
Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential
2 months ago - By: Yahoo Finance
Aquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside Potential
2 months ago - By: Zacks Investment Research
Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key Metrics Have to Say
2 months ago - By: Zacks Investment Research
- Mentions:
CASI
Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates
2 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Yahoo Finance
- Mentions:
BROS
CART
ATKR
TFC
...
Is Dutch Bros Inc. (BROS) Among the Best Restaurant Stocks to Buy According to Hedge Funds?
2 months ago - By: Benzinga
- Mentions:
LAND
EDIT
LINC
VTLE
...
Earnings Scheduled For May 12, 2025
3 months ago - By: Zacks Investment Research
- Mentions:
COLL
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
5 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
5 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
5 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
5 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
5 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
5 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
Please enable JavaScript to continue using this application.